0.56 -0.03 (-5.08%)
ADXS
| Trade ADXS now with |
Stock Details
Last Trade:0.56 Change:-0.03 (-5.08%) Prev Close:0.59 Open: 0.59 Days Range:0.54 – 0.59 52 Week Range: 5.21 - 16.30 Volume:839652 P/E: N/AEPS:-4.10
View AllRecent Alerts 03/28/20
Recent Alert on 03/13/20 at 9:00am
Advaxis Reports First Quarter Ended January 31, 2020 Financial Results and Provides a Pipeline Update
Advaxis Reports First Quarter Ended January 31, 2020 Financial Results and Provides a Pipeline Update
PRINCETON, N.J., March 13, 2020 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products today announced an update on its clinical pipeline... Read More
Recent Alert on 02/27/20 at 9:05am
Advaxis (ADXS) Reports Updated Positive Clinical Data in Ongoing Phase 1/2 ADXS-503 Trial in NSCLC
Advaxis (ADXS) Reports Updated Positive Clinical Data in Ongoing Phase 1/2 ADXS-503 Trial in NSCLC
Recent Alert on 02/27/20 at 9:00am
Advaxis Announces Updated Positive Clinical Data in Ongoing Phase 1/2 ADXS-503 Trial in NSCLC at I/O 360° Conference
Advaxis Announces Updated Positive Clinical Data in Ongoing Phase 1/2 ADXS-503 Trial in NSCLC at I/O 360° Conference
Recent Alert on 02/20/20 at 8:14am
Advaxis (ADXS) Reports Positive Clinical Data in Ongoing Phase 1/2 ADXS-503 Trial in NSCLC
Advaxis (ADXS) Reports Positive Clinical Data in Ongoing Phase 1/2 ADXS-503 Trial in NSCLC
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
No Recent Blog Posts Available